ADMA Company Profile and Key Details
ADMA Biologics, Inc.
ADMA Stock Price Chart
Stock Price Today
ADMA Biologics, Inc. (ADMA) stock surged +1.92%, trading at $16.47 on NASDAQ, up from the previous close of $16.16. The stock opened at $16.18, fluctuating between $15.95 and $16.49 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. The company also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.
Company Information
| Employees | 624 |
| Beta | 0.65 |
| Sales or Revenue | $258.21M |
| 5Y Sales Change% | 2.067% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
ADMA Biologics, Inc. (NASDAQ: ADMA) stock price is $16.47 in the last trading session. During the trading session, ADMA stock reached the peak price of $16.49 while $15.95 was the lowest point it dropped to. The percentage change in ADMA stock occurred in the recent session was 1.92% while the dollar amount for the price change in ADMA stock was $0.31.
The NASDAQ listed ADMA is part of Biotechnology industry that operates in the broader Healthcare sector. ADMA Biologics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Marc S. Gelberg
Senior Director & Corporation Controller
Mr. Drew Pantello
Vice President of Marketing & Corporation Devel.
Dr. Jerrold B. Grossman D.P.S., Ph.D.
Co-Founder & Vice Chairman
Mr. Brian Lenz CPA, CPA
Executive Vice President, Chief Financial Officer & GM of ADMA BioCenters
Dr. Gene A. Wetzstein BCOP, Pharm.D.
Executive Director & Head of Scientific Engagement
Mr. Michael Least
Vice President of Sales & Commercial Operations
Ms. Cyndi Tolman
Senior Vice President of Plasma Services
Mr. Adam S. Grossman
Co-Founder, Pres, Chief Executive Officer & Director
Mr. Brian Lenz C.P.A., CPA
Executive Vice President, Chief Financial Officer & GM of ADMA BioCenters
Ms. Cindy Petersen
Senior Director of HR
Mr. Michael Goldstein
Senior Director & Gen. Counsel
Mr. Skyler Bloom
Senior Director of Bus. Devel. & Corporation Strategy
Ms. Kaitlin Kestenberg
Senior Vice President of Compliance & Project Operations
Mr. Neal C. Fitzpatrick
Vice President of Sales
ADMA's closing price is 228.09% higher than its 52-week low of $5.02 where as its distance from 52-week high of $23.64 is -30.33%.
Number of ADMA employees currently stands at 624.
Official Website of ADMA is: https://www.admabiologics.com
ADMA could be contacted at phone 201 478 5552 and can also be accessed through its website. ADMA operates from 465 State Route 17, Ramsey, NJ 07446, United States.
ADMA stock volume for the day was 2.31M shares. The average number of ADMA shares traded daily for last 3 months was 2.99M.
The market value of ADMA currently stands at $3.89B with its latest stock price at $16.47 and 236.39M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com